Literature DB >> 7755272

Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro.

J B Delcarpio1, W C Claycomb.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7755272     DOI: 10.1111/j.1749-6632.1995.tb17437.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Adult-derived stem cells from the liver become myocytes in the heart in vivo.

Authors:  N N Malouf; W B Coleman; J W Grisham; R A Lininger; V J Madden; M Sproul; P A Anderson
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

Authors:  M G Klug; M H Soonpaa; G Y Koh; L J Field
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Cardiomyocytes can be generated from marrow stromal cells in vitro.

Authors:  S Makino; K Fukuda; S Miyoshi; F Konishi; H Kodama; J Pan; M Sano; T Takahashi; S Hori; H Abe; J Hata; A Umezawa; S Ogawa
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 4.  Application of mesenchymal stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy.

Authors:  Keiichi Fukuda
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

5.  Regeneration of cardiomyocytes from bone marrow: Use of mesenchymal stem cell for cardiovascular tissue engineering.

Authors:  Keiichi Fukuda
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

6.  Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation.

Authors:  Mukesh K Gupta; Joel M Walthall; Raghav Venkataraman; Spencer W Crowder; Dae Kwang Jung; Shann S Yu; Tromondae K Feaster; Xintong Wang; Todd D Giorgio; Charles C Hong; Franz J Baudenbacher; Antonis K Hatzopoulos; Hak-Joon Sung
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.